VIDA VENTURES ADVISORS, LLC

PrivateCIK: 1831423
Location

BOSTON, MA

πŸ“‹ What this filing means

VIDA VENTURES ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $91.43M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

5
Positions
$91.43M
Total AUM (reported)
13.43M
Total Shares

Allocation by class

TOTAL AUM$91.43M5 positions
COMMON STOCK$55.93M61.2%
ORDINARY SHARES$35.50M38.8%

Portfolio Concentration

Top 391.7%4–108.3%TOP 10100.0%0%100%
Top 3$83.81M91.7%
4–10$7.62M8.3%

Top 3 weight

91.7%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 13.43M

Sole

Full voting authority

13.43M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole5
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings5
Rows:

Centessa Pharmaceuticals plc

SOLE
Ordinary Shares
Shares3.93M
TypeSH
Market value$35.50M
38.83%
Sole
3.93M
Shared
0.00
None
0.00

Kyverna Therapeutics, Inc.

SOLE
Common Stock
Shares4.52M
TypeSH
Market value$33.93M
37.11%
Sole
4.52M
Shared
0.00
None
0.00

Dyne Therapeutics, Inc.

SOLE
Common Stock
Shares407.50K
TypeSH
Market value$14.38M
15.73%
Sole
407.50K
Shared
0.00
None
0.00

Allogene Therapeutics, Inc.

SOLE
Common Stock
Shares1.80M
TypeSH
Market value$4.19M
4.58%
Sole
1.80M
Shared
0.00
None
0.00

Kronos Bio, Inc.

SOLE
Common Stock
Shares2.77M
TypeSH
Market value$3.43M
3.75%
Sole
2.77M
Shared
0.00
None
0.00
VIDA VENTURES ADVISORS, LLC 13F Holdings β€” 5 Positions | Finecho